Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
The document reports the completion of a clinical trial evaluating psychosocial adjustment after radiation therapy in cancer patients.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: GP Extended Action Triptorelin [Phase 4]
The Phase 4 trial of GP Extended Action Triptorelin for prostate cancer was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer [Phase 4]
Phase 4 trial evaluating the efficacy and safety of ELIGARD 22.5 mg in prostate cancer has been completed.
-
CLINICAL_TRIALS withdrawal · 2015-09-23Clinical Trial Update: Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer [NA]
The clinical trial evaluating targeted biopsies and cytological imprints in prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections [NA]
The clinical trial NCT02185170, titled DEPORRA-CoProst, assessed new fluorescence imaging techniques using prostate tissue chips from transu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-18Clinical Trial Update: A Study of Pertuzumab in Participants With Prostate Cancer [Phase 2]
Phase 2 trial of pertuzumab in prostate cancer was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 study assessing the efficacy, pharmacokinetics, and safety of two subcutaneous injections of a six-month triptorelin embonate form…
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? [Phase 3]
Phase 3 trial evaluating tadalafil to maintain erectile function in patients with prostate cancer treated with radiotherapy; the study has b…
-
CLINICAL_TRIALS trial_result · 2015-09-11Clinical Trial Update: Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate Cancer
Clinical trial update describing daily target guided radiation therapy using the Calypso 4D localization system in patients who have undergo…
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient [Phase 1, Phase 2]
Phase 1/2 safety and efficacy study of Mix Vaccine in prostate cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 [Phase 2]
Extension phase 2 study update for YM-155 in prostate cancer, melanoma, and non-Hodgkin lymphoma; status completed.
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling [Phase 2]
Phase 2 study of STA-9090 (ganetespib) in castration-resistant prostate cancer was withdrawn. The trial included assessment of androgen rece…
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer [Phase 2, Phase 3]
This clinical trial update reports termination of a Phase 2/3 study evaluating external beam radiation with or without chemotherapy for high…
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer [Phase 2]
Phase 2 trial in prostate cancer after definitive local therapy evaluating docetaxel, bevacizumab, and androgen deprivation therapy has comp…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography [Phase 1]
Phase 1 clinical trial evaluating the radiotracer 68Ga-NOTA-AE105 for PET-based diagnosis of aggressive cancers, including breast cancer, pr…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer
This is a completed clinical trial update evaluating the effectiveness and safety of Firmagon (degarelix) for patients with advanced prostat…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002) [Phase 2]
A Phase 2 clinical trial evaluating the combination of bicalutamide and ridaforolimus for prostate cancer has completed.
-
FDA approval · 2015-08-18FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ZYTIGA (abiraterone acetate) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: FACBC PET/CT for Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial results for FACBC PET/CT in detecting recurrent prostate cancer have been completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer [Phase 1, Phase 2]
Phase I/II trial evaluating an antigen-loaded dendritic cell vaccine for hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients [Phase 3]
Phase 3 trial of lanreotide in non-metastatic castration-resistant prostate cancer was terminated; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors [Phase 1, Phase 2]
Open-label Phase 1/2 trial evaluating YM155 in combination with docetaxel in advanced hormone-refractory prostate cancer and other solid tum…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness [Phase 2]
Phase II trial evaluating purified isoflavones in prostate cancer completed with results posted in 2015.
-
FDA approval · 2015-08-05FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, Inc. The approval expands the labelin…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Deep Neuromuscular Blockade During Robotic Radical Prostatectomy [Phase 4]
Phase 4 clinical trial update evaluating deep neuromuscular blockade during robotic radical prostatectomy; current status is unknown.